A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.

A fourth dose of bivalent or monovalent BA.1-adapted BNT162b2 vaccines was safe and elicited robust neutralizing responses in adults aged 18 to 55 years.

NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a new agreement with the European Commission (EC) to supply 900 million doses of ...

Feb 23 (Reuters) - Use of hepatitis B vaccines in U.S. newborns was declining well before the Centers for Disease Control and Prevention scrapped a longstanding broad recommendation for the shots in ...

A comprehensive review of the medical literature supports the longstanding practice of administering the hepatitis B vaccine to all medically stable infants at birth. The study, published in ...

Hepatitis B vaccination of US newborns declined before CDC guideline change Rates dropped markedly between 2023 and 2025 Start of decline coincides with podcast featuring vaccine critic Robert F.

Moderna (MRNA) faces a lawsuit in the U.S. for allegedly infringing patent rights related to the COVID-19 shot developed by Pfizer (PFE) and BioNTech (BNTX), marking the latest such case among ...

The U.S. Food and Drug Administration announced recently that it will not review Moderna’s mRNA flu vaccine, despite late-stage trials showing it was safe and effective. The rejection has many in and ...

Dr. Raza Bokhari, Executive Chairman & CEO will participate in panel discussions and highlight Company's AI-enabled Drug ...

The Food and Drug Administration has reversed its shocking refusal to consider Moderna’s mRNA flu vaccine for approval. The refusal was revealed last week in a sharply worded press release from ...

Measles cases have soared nationwide in the first two months of 2026. According to the Centers for Disease Control and Prevention’s most recent data, 982 cases of the highly contagious disease have ...